Literature DB >> 19082524

Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Lars Wöckel1, Florian Daniel Zepf, Sabrina Koch, Anikó-Eva Meyer-Keitel, Martin H Schmidt.   

Abstract

Numerous symptoms related to eating disorders have been shown to be influenced by serotonergic (5-HT) functioning, with the 5-HT(2A) receptor subtype being one of the most relevant involved in the pathophysiology of bulimia nervosa (BN). In line with this, Ca(2+) mobilization as mediated by 5-HT(2) receptors in platelets was shown to serve as a peripheral model for central nervous 5-HT functioning. Here, the 5-HT-induced intracellular Ca(2+) mobilization in platelets was measured in 13 female normal weight bulimic patients (14-18 years) upon admission and at the end of inpatient treatment. Findings were compared to 21 age-matched healthy female adolescents. 5-HT-induced Ca(2+) release was significantly decreased in bulimic patients upon admission and normalized during inpatient treatment. Antidepressive medication caused a significant improvement. The data provide further evidence that altered 5-HT(2) receptor functioning is involved in the pathophysiological underpinnings in BN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082524     DOI: 10.1007/s00702-008-0163-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  78 in total

1.  CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity.

Authors:  W H Kaye; J C Ballenger; R B Lydiard; G W Stuart; M T Laraia; P O'Neil; M D Fossey; V Stevens; S Lesser; G Hsu
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

Review 2.  Treatment of bulimia nervosa: where are we and where are we going?

Authors:  James E Mitchell; Stewart Agras; Stephen Wonderlich
Journal:  Int J Eat Disord       Date:  2007-03       Impact factor: 4.861

Review 3.  Pharmacotherapy of bulimia nervosa and binge eating disorder.

Authors:  B T Walsh; M J Devlin
Journal:  Addict Behav       Date:  1995 Nov-Dec       Impact factor: 3.913

4.  Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.

Authors:  R D Levitan; A S Kaplan; R T Joffe; A J Levitt; G M Brown
Journal:  Arch Gen Psychiatry       Date:  1997-06

5.  Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa.

Authors:  H Steiger; S N Young; N M Kin; N Koerner; M Israel; P Lageix; J Paris
Journal:  Psychol Med       Date:  2001-01       Impact factor: 7.723

6.  Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa.

Authors:  Marta Ribasés; Fernando Fernández-Aranda; Mònica Gratacòs; Josep M Mercader; Carolina Casasnovas; Araceli Núñez; Julio Vallejo; Xavier Estivill
Journal:  J Psychiatr Res       Date:  2006-10-20       Impact factor: 4.791

7.  Use of reboxetine in bulimia nervosa: a pilot study.

Authors:  Secondo Fassino; Giovanni Abbate Daga; Sonia Boggio; Lorenzo Garzaro; Andrea Pierò
Journal:  J Psychopharmacol       Date:  2004-09       Impact factor: 4.153

8.  Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders.

Authors:  Carla E Ramacciotti; Elisabetta Coli; Riccardo Paoli; Donatella Marazziti; Liliana Dell'Osso
Journal:  Psychiatry Res       Date:  2003-05-01       Impact factor: 3.222

9.  Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors.

Authors:  P Erne; A Pletscher
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

10.  Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.

Authors:  D M Helmeste; S W Tang; C Reist; R Vu
Journal:  Eur J Pharmacol       Date:  1995-02-15       Impact factor: 4.432

View more
  2 in total

Review 1.  Canadian practice guidelines for the treatment of children and adolescents with eating disorders.

Authors:  Jennifer Couturier; Leanna Isserlin; Mark Norris; Wendy Spettigue; Melissa Brouwers; Melissa Kimber; Gail McVey; Cheryl Webb; Sheri Findlay; Neera Bhatnagar; Natasha Snelgrove; Amanda Ritsma; Wendy Preskow; Catherine Miller; Jennifer Coelho; Ahmed Boachie; Cathleen Steinegger; Rachel Loewen; Techiya Loewen; Elizabeth Waite; Catherine Ford; Kerry Bourret; Joanne Gusella; Josie Geller; Adele LaFrance; Anick LeClerc; Jennifer Scarborough; Seena Grewal; Monique Jericho; Gina Dimitropoulos; David Pilon
Journal:  J Eat Disord       Date:  2020-02-01

Review 2.  Outcomes of inpatient psychological treatments for children and adolescents with eating disorders at time of discharge: a systematic review.

Authors:  Leanna Isserlin; Wendy Spettigue; Mark Norris; Jennifer Couturier
Journal:  J Eat Disord       Date:  2020-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.